Lin Yu-Hsin
Transaction: 08/12/2026
SELL
Change
-223
Price
$180.57
Filing
08/14/2026
Type
SELL
Belite Bio, Inc
BLTE • Biotechnology
$154.30
▼ -0.15 (-0.10%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$6.15B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 50.02Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 20, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:47 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$154.30
Change-0.10%
Shares Out39.87M
Market Cap$6.15B
Enterprise Value$6.15B
52W Range60.00 - 200.00
Beta-1.23
P/E-68.10
P/B7.73
P/FCF-582.01
EV/EBITDA-60.62
EV/FCF-582.01
Price$154.30
Change-0.10%
Shares Out39.87M
Market Cap$6.15B
Enterprise Value$6.15B
52W Range60.00 - 200.00
Beta-1.23
P/E-68.10
P/B7.73
P/FCF-582.01
EV/EBITDA-60.62
EV/FCF-582.01
Earnings Yield-1.47%
FCF Yield-0.17%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio50.02
Quick Ratio50.02
Target$245.83
Target Upside59.32%
Target Median$239.50
Target Range206.00 - 303.00
Volume490.10K
Avg Volume182.42K
EPS Surprise0.26
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
45/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 50.02Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-10-20
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$214.00
Mean
$217.00
Median
$217.00
High
$220.00
Insider Transactions
Recent executive and insider activity
Chuang Hao-Yuan
Transaction: 08/12/2026
SELL
Change
-223
Price
$180.57
Filing
08/14/2026
Type
SELL
Scholl Hendrik Peter
Transaction: 06/18/2026
SELL
Change
-96
Price
$147.11
Filing
06/22/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lin Yu-Hsin | SELL | -223 | $180.57 | 08/12/2026 | 08/14/2026 |
| Chuang Hao-Yuan | SELL | -223 | $180.57 | 08/12/2026 | 08/14/2026 |
| Scholl Hendrik Peter | SELL | -96 | $147.11 | 06/18/2026 | 06/22/2026 |
| Scholl Hendrik Peter | SELL | -1,035 | $145.02 | 06/16/2026 | 06/17/2026 |
| MATA NATHAN L. | SELL | -9 | $155.25 | 05/07/2026 | 05/08/2026 |
| MATA NATHAN L. | SELL | -100 | $156.00 | 05/06/2026 | 05/07/2026 |
| MATA NATHAN L. | SELL | -68 | $158.11 | 05/05/2026 | 05/06/2026 |
| MATA NATHAN L. | SELL | -172 | $157.49 | 05/04/2026 | 05/05/2026 |
| MATA NATHAN L. | SELL | -23 | $160.00 | 05/01/2026 | 05/04/2026 |
| MATA NATHAN L. | SELL | -101 | $158.15 | 04/30/2026 | 05/01/2026 |
| MATA NATHAN L. | SELL | -22 | $158.19 | 04/29/2026 | 04/30/2026 |
| MATA NATHAN L. | SELL | -54 | $162.14 | 04/28/2026 | 04/29/2026 |
| MATA NATHAN L. | SELL | -36 | $164.07 | 04/27/2026 | 04/28/2026 |
| MATA NATHAN L. | SELL | -3 | $162.53 | 04/24/2026 | 04/27/2026 |
| MATA NATHAN L. | SELL | -21 | $169.56 | 04/23/2026 | 04/24/2026 |
| MATA NATHAN L. | SELL | -21 | $173.04 | 04/22/2026 | 04/23/2026 |
| Chuang Hao-Yuan | BUY | +10,000 | Not reported | 04/21/2026 | 04/23/2026 |
| Scholl Hendrik Peter | BUY | +10,000 | $77.40 | 04/21/2026 | 04/23/2026 |
| Lin Yu-Hsin | BUY | +10,000 | Not reported | 04/21/2026 | 04/23/2026 |
| MATA NATHAN L. | SELL | -214 | $167.34 | 04/21/2026 | 04/22/2026 |